2 most recent filings and news items mentioning SRPT. Updated every 60 seconds.
LeadershipJul 27, 2026Neutral
Sarepta Therapeutics announced a new employment agreement with Michael Severino M.D. effective July 28, 2026, to serve as the company's Chief Executive Officer and Board member. This move signals a planned leadership transition and serves to provide continuity for the biopharmace
View filing at SEC.gov →
OtherJun 4, 2026Neutral
Sarepta Therapeutics adopted a new equity incentive plan authorizing 6.74 million shares for stock and stock-based awards to employees and participants. The plan replaces prior equity plans and includes standard provisions for stock options, SARs, and other equity awards with adm
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.